Aminat Ibikunle

Aminat Ibikunle practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

Aminat Ibikunle's NPI, 1447756325, was assigned on April 1, 2018. Aminat Ibikunle graduated from New York University School of Medicine in 2018. Aminat Ibikunle holds Maryland license D0092387.

Aminat Ibikunle's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

Aminat Ibikunle's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. Aminat Ibikunle is also affiliated with Shenandoah Memorial Hospital. The medical group on file is Presbyterian Medical Group. Dmand AI also links Aminat Ibikunle to 4 more hospitals, 9 medical groups and 2 group practices and clinics, each named with a free account. Aminat Ibikunle's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Aminat Ibikunle practices, 8 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Aminat Ibikunle's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Aminat Ibikunle is licensed in Maryland.

CMS data shows 269 Medicare services from Aminat Ibikunle across 4 procedure codes in 2024, for 262 Medicare patients. Medicare paid $39,242 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 262 Medicare patients who saw Aminat Ibikunle in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Aminat Ibikunle's median patient age at 49, with 59% women.

In 2024, Aminat Ibikunle wrote 51 Medicare Part D claims for 38 patients. 100% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $183 in total drug cost. In 2022, CMS named 26 claims across 2 drugs.

Aminat Ibikunle accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Aminat Ibikunle from 2 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $72.

Aminat Ibikunle graduated from New York University School of Medicine in 2018.